Carisma Therapeutics, Inc. (CARM)

Carisma Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	7.74	17.91	77.61	24.19	28.55	51.79
Short-Term Investments	0.85	0.93	0.89	27.8	-	-
Cash & Short-Term Investments	8.59	18.83	78.5	52	28.55	51.79
Cash Growth	-85.21%	-76.01%	50.97%	82.12%	-44.87%	-
Receivables	-	2.86	-	-	-	-
Prepaid Expenses	0.72	0.34	0.4	2.6	1.24	1.28
Other Current Assets	4.65	1.79	1.57	-	-	-
Total Current Assets	13.95	23.83	80.47	54.59	29.79	53.07
Property, Plant & Equipment	2	6.43	8.94	13.45	5.66	5.19
Long-Term Deferred Charges	-	0.21	0.15	4.11	-	-
Other Long-Term Assets	-	-	-	-	-	0.21
Total Assets	15.95	30.46	89.55	72.15	35.45	58.46
Accounts Payable	3.25	2.08	3.93	1.73	2.32	3.29
Accrued Expenses	4.71	7.45	7.66	10.36	4.47	1.57
Current Portion of Leases	1.64	1.74	1.94	4.6	0.9	0.81
Current Unearned Revenue	-	3.73	1.41	2.46	-	-
Other Current Liabilities	0.85	1.06	0.97	0.52	-	-
Total Current Liabilities	10.45	16.06	15.91	19.67	7.69	5.68
Long-Term Debt	-	-	-	33.72	-	-
Long-Term Leases	0.69	0.74	1.19	1.85	1.73	2.63
Long-Term Unearned Revenue	41.25	41.25	45	45	-	-
Other Long-Term Liabilities	0.23	0.32	0.93	6.78	-	-
Total Liabilities	52.62	58.37	63.02	107.02	9.43	8.31
Common Stock	0.04	0.04	0.04	0	-	-
Additional Paid-In Capital	278.14	277.63	271.59	1.2	0.82	0.34
Retained Earnings	-314.85	-305.58	-245.1	-158.22	-97	-56.21
Comprehensive Income & Other	-	-	-	-0.04	-	-
Total Common Equity	-36.66	-27.91	26.53	-157.07	-96.18	-55.87
Minority Interest	-	-	-	14.4	14.4	14.4
Shareholders' Equity	-36.66	-27.91	26.53	-34.86	26.02	50.15
Total Liabilities & Equity	15.95	30.46	89.55	72.15	35.45	58.46
Total Debt	2.33	2.48	3.12	40.16	2.63	3.45
Net Cash (Debt)	6.26	16.35	75.37	11.83	25.92	48.34
Net Cash Growth	-87.62%	-78.30%	537.03%	-54.35%	-46.38%	-
Net Cash Per Share	0.15	0.39	2.25	5.56	23.91	45.46
Filing Date Shares Outstanding	41.79	41.79	41.54	1.17	11.09	1.06
Total Common Shares Outstanding	41.79	41.75	40.61	1.17	1.08	1.06
Working Capital	3.51	7.77	64.56	34.92	22.1	47.39
Book Value Per Share	-0.88	-0.67	0.65	-134.52	-88.72	-52.55
Tangible Book Value	-36.66	-27.91	26.53	-157.07	-96.18	-55.87
Tangible Book Value Per Share	-0.88	-0.67	0.65	-134.52	-88.72	-52.55
Machinery	-	4.82	5.36	7.63	3.96	2.09
Construction In Progress	-	-	0.01	0.01	0.01	-
Leasehold Improvements	-	0.34	0.34	0.34	0.32	0.32

Updated Mar 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q